Author

A. Kirmaier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Gaba· 1 shared A. Morgan· 1 shared A.-R. Y. Collier· 1 shared B. H. Hahn· 1 shared C. Callahan· 1 shared C. M. Stürzel· 1 shared D. H. Barouch· 1 shared D. Kmiec· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Gaba

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Contrasting Effects of SARS-CoV-2 Vaccination vs. Infection on Antibody and TCR Repertoires

J. Braun, E. D. Hill, E. Contreras, M. Yasuda, A. Morgan, S. Ditelberg, E. Winter, C. Callahan, G. Mazzoni, A. Kirmaier, H. Mirebrahim, H. Asgharian, D. Telman, A.-R. Y. Collier, D. H. Barouch, , R. Arnaout

This study compares antibody and TCR repertoires in SARS-CoV-2 infectees, vaccinees, and controls to predict neutralizing antibody titers and identifies subtle differences in adaptive immune responses.

bioRxiv · Sep 8, 2023 · PreprintImmunology

Species-specific differences in antagonism of APOBEC3 proteins by HIV-2 and SIVsmm Vif proteins

R. Nchioua, D. Kmiec, A. Gaba, C. M. Stürzel, T. Follack, S. Patrick, A. Kirmaier, W. E. Johnson, B. H. Hahn, L. Chelico, F. Kirchhoff

This study compares the ability of HIV-2 and SIVsmm Vif proteins to counteract human APOBEC3 proteins, showing HIV-2 acquired adaptive changes for efficient counteraction in humans.

bioRxiv · Sep 8, 2020 · PreprintImmunology